Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Bank of Korea: There is a gap between overseas investment income and foreign exchange inflow, providing weaker support for the Korean won than expected

Bank of Korea: There is a gap between overseas investment income and foreign exchange inflow, providing weaker support for the Korean won than expected

金十金十2026/06/18 03:54
Show original
Golden Ten Data reported on June 18 that a study by the South Korean central bank indicated that investment income derived from overseas assets may provide less support for the Korean won than previously expected. This is because a large portion of these funds are retained abroad and continually reinvested, rather than being remitted back to South Korea, resulting in a gap between the headline investment income surplus and actual foreign exchange inflows. As overseas investment continues to grow rapidly, this issue is becoming increasingly prominent. The research suggests that this phenomenon helps to explain why, despite strong South Korean semiconductor exports and the current account surplus approaching historical highs recently, the won remains relatively weak. Since the start of this year, the won has depreciated by more than 5%, making it one of the worst-performing Asian currencies. Therefore, policymakers not only need to focus on the scale of investment income, but also on the proportion that is repatriated. The report estimates that if the scale of overseas investment rises by about 3% relative to the average level, this would push the USD/KRW exchange rate up by approximately 0.7 percentage points, reflecting increased demand for foreign currency; conversely, if investment income rises around 8% above the average, the exchange rate could decline by about 0.4 percentage points.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.

U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).

智通财经2026/09/21 07:11

Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential

According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.

智通财经2026/09/21 07:11

Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US listing, plans to raise up to 100 millions dollars.

TRex Bio filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday, intending to raise up to 100 million USD through an initial public offering (IPO).

智通财经2026/09/21 07:11